Apr 27, 2021
Includes Pivotal Phase 3 Alzheimer’s Asset NE3107
Mar 11, 2021
SANTA MONICA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today announced the participation of its management team in the 31st Annual Oppenheimer Healthcare Conferenc...
Mar 9, 2021
SANTA MONICA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today announced the start of patient screening in the Company’s Phase 2 Trial of BIV201 (continuous infusi...